320 related articles for article (PubMed ID: 38605021)
1. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
2. [Gastric neuroendocrine tumors].
Alekberzade AV; Krylov NN; Lipnitskiy EM; Shakhbazov RO; Azari F
Khirurgiia (Mosk); 2019; (12):111-120. PubMed ID: 31825351
[TBL] [Abstract][Full Text] [Related]
3. Gastric neuroendocrine tumours.
Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
[TBL] [Abstract][Full Text] [Related]
4. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
5. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
7. Gastric and duodenal neuroendocrine tumours.
O'Toole D; Delle Fave G; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
[TBL] [Abstract][Full Text] [Related]
8. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.
Magris R; De Re V; Maiero S; Fornasarig M; Guarnieri G; Caggiari L; Mazzon C; Zanette G; Steffan A; Canzonieri V; Cannizzaro R
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00238. PubMed ID: 33094954
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
[TBL] [Abstract][Full Text] [Related]
10. The Morphologic Spectrum of Gastric Type 1 Enterochromaffin-Like Cell Neuroendocrine Tumors.
Poveda JC; Chahar S; Garcia-Buitrago MT; Montgomery EA; McDonald OG
Mod Pathol; 2023 Apr; 36(4):100098. PubMed ID: 36913909
[TBL] [Abstract][Full Text] [Related]
11. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine neoplasia of the stomach : What is new?].
Knösel T; Reiter C; Schubert-Fritschle G; Altendorf-Hofmann A; Kirchner T
Pathologe; 2017 Mar; 38(2):98-104. PubMed ID: 28188377
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U
Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
[TBL] [Abstract][Full Text] [Related]
14. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract][Full Text] [Related]
15. Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.
Rais R; Trikalinos NA; Liu J; Chatterjee D
Arch Pathol Lab Med; 2022 Mar; 146(3):366-371. PubMed ID: 34283890
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
[TBL] [Abstract][Full Text] [Related]
17. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumors of the Stomach.
Corey B; Chen H
Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
[TBL] [Abstract][Full Text] [Related]
19. Gastric neuroendocrine tumors.
Delle Fave G; Capurso G; Annibale B; Panzuto F
Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
[TBL] [Abstract][Full Text] [Related]
20. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
